Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Milid
2. Xilamide
3. Xylamide
1. 6620-60-6
2. 4-benzamido-5-(dipropylamino)-5-oxopentanoic Acid
3. Binoside
4. Xylamide
5. Dl-proglumide
6. Nulsa
7. Gastrotopic
8. Midelid
9. Ulcutin
10. Milid
11. Xyde
12. Proglumidum
13. Proglumida
14. Pentanoic Acid, 4-(benzoylamino)-5-(dipropylamino)-5-oxo-
15. Promid
16. W-5219
17. (+-)-4-benzamido-n,n-dipropylglutaramic Acid
18. Cr-242
19. Nsc-757841
20. Glutaramic Acid, 4-benzamido-n,n-dipropyl-, Dl-
21. Pentanoic Acid, 4-(benzoylamino)-5-(dipropylamino)-5-oxo-, (+-)-
22. 4-(benzoylamino)-5-(dipropylamino)-5-oxopentanoic Acid
23. Chembl316561
24. Epl8w5565d
25. Chebi:32058
26. Milide
27. Dsstox_cid_3516
28. Dsstox_rid_77060
29. Dsstox_gsid_23516
30. Progumide
31. Proglumidum [inn-latin]
32. Proglumida [inn-spanish]
33. Promide (parasympatholytic)
34. Cr 242
35. 24485-90-3
36. Xylamide (gastroprotective Agent)
37. Sr-01000002970
38. Einecs 229-567-4
39. 242 Dl
40. W 5219
41. Brn 4151696
42. Unii-epl8w5565d
43. Racemic Proglumide
44. (rs)-proglumide
45. Proglumide,(s)
46. Proglumide [usan:inn:ban:jan]
47. Ncgc00016676-01
48. (+-)-proglumide
49. Prestwick_602
50. Cas-6620-60-6
51. Nulsa (tn)
52. Spectrum_001332
53. Proglumide [mi]
54. Dl-4-benzamido-n,n-dipropylglutaramic Acid
55. Proglumide [inn]
56. Proglumide [jan]
57. Prestwick0_000240
58. Prestwick1_000240
59. Prestwick2_000240
60. Prestwick3_000240
61. Spectrum2_001406
62. Spectrum3_001444
63. Spectrum4_000425
64. Spectrum5_001591
65. Proglumide [usan]
66. Proglumide [mart.]
67. (+/-)-4-benzamido-n,n-dipropylglutaramic Acid
68. Proglumide [who-dd]
69. Lopac0_000832
70. Schembl93339
71. Bspbio_000319
72. Bspbio_002907
73. Gtpl893
74. Kbiogr_000750
75. Kbioss_001812
76. Mls002154246
77. Divk1c_000684
78. Spectrum1501119
79. Spbio_001452
80. Spbio_002240
81. Amy374
82. Bpbio1_000351
83. Dtxsid7023516
84. Proglumide (jp17/usan/inn)
85. Schembl19994752
86. Chebi:76266
87. Hms502c06
88. Kbio1_000684
89. Kbio2_001812
90. Kbio2_004380
91. Kbio2_006948
92. Kbio3_002407
93. Ninds_000684
94. Hms1568p21
95. Hms1921f19
96. Hms2092d13
97. Hms2095p21
98. Hms2235b24
99. Hms3262h05
100. Hms3369d14
101. Hms3712p21
102. Pharmakon1600-01501119
103. Hy-b1330
104. Tox21_110557
105. Tox21_500832
106. Bdbm50014888
107. Ccg-39024
108. Mfcd00055071
109. Nsc757841
110. Akos015895810
111. Tox21_110557_1
112. Ac-1274
113. Cs-8029
114. Db13431
115. Ks-1212
116. Lp00832
117. Nsc 757841
118. Sdccgsbi-0050809.p004
119. 4-benzamido-n,n-dipropylglutaramic Acid
120. Idi1_000684
121. N2-benzoyl-n,n-dipropyl-alpha-glutamine
122. Ncgc00015623-03
123. Ncgc00015623-04
124. Ncgc00015623-05
125. Ncgc00015623-06
126. Ncgc00015623-07
127. Ncgc00015623-10
128. Ncgc00015623-14
129. Ncgc00094163-01
130. Ncgc00094163-02
131. Ncgc00094163-03
132. Ncgc00094163-04
133. Ncgc00261517-01
134. Bp166197
135. Smr001233513
136. Sbi-0050809.p003
137. N(2)-benzoyl-n,n-dipropyl-alpha-glutamine
138. Ab00052206
139. Eu-0100832
140. Ft-0654938
141. M-001
142. N2-(phenylcarbonyl)-n,n-dipropyl-a-glutamine
143. 4-benzoylamino-4-dipropylcarbamoyl-butyric Acid
144. D01818
145. Rac-n(2)-benzoyl-n,n-dipropyl-alpha-glutamine
146. Ab00052206_08
147. 4-benzoylamino-5-dipropylamino-5-oxopentanoic Acid
148. 620p606
149. N~2~-(phenylcarbonyl)-n,n-dipropyl-alpha-glutamine
150. Q7248362
151. Sr-01000002970-2
152. Sr-01000002970-4
153. Sr-01000002970-7
154. W-104770
155. 4-(benzoylamino)-5-(dipropylamino)-5-oxovaleric Acid
156. Brd-a44863528-001-05-8
157. Brd-a44863528-001-08-2
158. 4-(benzoylamino)-5-(dipropylamino)-5-oxo-pentanoic Acid
159. Pentanoic Acid, 4-(benzoylamino)-5-(dipropylamino)-5-oxo-, (+/-)-
| Molecular Weight | 334.4 g/mol |
|---|---|
| Molecular Formula | C18H26N2O4 |
| XLogP3 | 2.4 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 10 |
| Exact Mass | 334.18925731 g/mol |
| Monoisotopic Mass | 334.18925731 g/mol |
| Topological Polar Surface Area | 86.7 Ų |
| Heavy Atom Count | 24 |
| Formal Charge | 0 |
| Complexity | 413 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Anti-Ulcer Agents
Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)
A - Alimentary tract and metabolism
A02 - Drugs for acid related disorders
A02B - Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord)
A02BX - Other drugs for peptic ulcer and gastro-oesophageal reflux disease (gord)
A02BX06 - Proglumide
ABOUT THIS PAGE
A Proglumide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Proglumide, including repackagers and relabelers. The FDA regulates Proglumide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Proglumide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Proglumide supplier is an individual or a company that provides Proglumide active pharmaceutical ingredient (API) or Proglumide finished formulations upon request. The Proglumide suppliers may include Proglumide API manufacturers, exporters, distributors and traders.
click here to find a list of Proglumide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Proglumide DMF (Drug Master File) is a document detailing the whole manufacturing process of Proglumide active pharmaceutical ingredient (API) in detail. Different forms of Proglumide DMFs exist exist since differing nations have different regulations, such as Proglumide USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Proglumide DMF submitted to regulatory agencies in the US is known as a USDMF. Proglumide USDMF includes data on Proglumide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Proglumide USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Proglumide suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Proglumide as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Proglumide API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Proglumide as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Proglumide and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Proglumide NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Proglumide suppliers with NDC on PharmaCompass.
Proglumide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Proglumide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Proglumide GMP manufacturer or Proglumide GMP API supplier for your needs.
A Proglumide CoA (Certificate of Analysis) is a formal document that attests to Proglumide's compliance with Proglumide specifications and serves as a tool for batch-level quality control.
Proglumide CoA mostly includes findings from lab analyses of a specific batch. For each Proglumide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Proglumide may be tested according to a variety of international standards, such as European Pharmacopoeia (Proglumide EP), Proglumide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Proglumide USP).
LOOKING FOR A SUPPLIER?
